| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000032533 |
| Receipt No. | R000037090 |
| Scientific Title | Effect of ingesting the beverages with different contents of carbohydrate and fat on exercise performance in the well-trained university students |
| Date of disclosure of the study information | 2018/05/10 |
| Last modified on | 2019/11/10 (Ver. 6) |
| Basic information | ||
| Public title | Effect of ingesting the beverages with different contents of carbohydrate and fat on exercise performance in the well-trained university students | |
| Acronym | Effect of ingesting the beverages with different contents of carbohydrate and fat on exercise performance | |
| Scientific Title | Effect of ingesting the beverages with different contents of carbohydrate and fat on exercise performance in the well-trained university students | |
| Scientific Title:Acronym | Effect of ingesting the beverages with different contents of carbohydrate and fat on exercise performance | |
| Region |
|
|
| Condition | ||
| Condition | Normal | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effets of ingesting the beverages with different contents of carbohydrate and fat on exercise performance and insulin secretion in the well-trained university students. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1.Stroop test during cycle ergometer exercise
2.Area under the curve for insulin level after ingestion of the test solution |
| Key secondary outcomes | 1.Blood glucose levels after ingestion of the test solution
2.Glucose-dependent insulinotropic polypeptide (GIP)level after ingestion of the test solution 3.Rating of perceived exertion during cycle ergometer exercise |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 6 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Cycle ergometer exercise(30min,140-150bpm, stroop test)
>Blood sampling >Ingestion of a test A solution(CHO 0.5g/kg body weight+250mL Water) >Blood samplings(15,30,60,120min after ingestion) >Cycle ergometer(30min, 140-150bpm, stroop test) >Blood sampling. All subjects will receive 6 treatments(test solution A-F) on 6 separate days over an interval of at least 6 days. |
|
| Interventions/Control_2 | Cycle ergometer exercise(30min,140-150bpm, stroop test)
>Blood sampling >Ingestion of a test B solution(CHO 0.5g/kg body weight+250mL Milk) >Blood samplings(15,30,60,120min after ingestion) >Cycle ergometer(30min, 140-150bpm, stroop test) >Blood sampling. |
|
| Interventions/Control_3 | Cycle ergometer exercise(30min,140-150bpm, stroop test)
>Blood sampling >Ingestion of a test C solution(CHO 0.5g/kg body weight+250mL High fat milk) >Blood samplings(15,30,60,120min after ingestion) >Cycle ergometer(30min, 140-150bpm, stroop test) >Blood sampling. |
|
| Interventions/Control_4 | Cycle ergometer exercise(30min,140-150bpm, stroop test)
>Blood sampling >Ingestion of a test D solution(CHO 1.0g/kg body weight+250mL Water) >Blood samplings(15,30,60,120min after ingestion) >Cycle ergometer(30min, 140-150bpm, stroop test) >Blood sampling. |
|
| Interventions/Control_5 | Cycle ergometer exercise(30min,140-150bpm, stroop test)
>Blood sampling >Ingestion of a test E solution(CHO 1.0g/kg body weight+250mL Milk) >Blood samplings(15,30,60,120min after ingestion) >Cycle ergometer(30min, 140-150bpm, stroop test) >Blood sampling. |
|
| Interventions/Control_6 | Cycle ergometer exercise(30min,140-150bpm, stroop test)
>Blood sampling >Ingestion of a test F solution(CHO 1.0g/kg body weight+250mL High fat milk) >Blood samplings(15,30,60,120min after ingestion) >Cycle ergometer(30min, 140-150bpm, stroop test) >Blood sampling. |
|
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy university students who have th
e exercise habit and have given written i nformed consent |
|||
| Key exclusion criteria | Subjects
1)who have heart disease and/or respiratory disease and/or injury 2)who having take medicine 3)with food allergies 4)who having a smoking habit 5)who had a food-dependent exercise-induced anaphylaxis 6)who are judged as ineligible by the doctor for other reasons |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Takasaki University of Health and Welfare | ||||||
| Division name | Health and Welfare | ||||||
| Zip code | 3700033 | ||||||
| Address | 37-1, Nakaorui-machi, Takasaki city, Gunma, 370-0033, Japan | ||||||
| TEL | 027-352-1290 | ||||||
| kimura@takasaki-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Takasaki University of Health and Welfare | ||||||
| Division name | Health and Welfare | ||||||
| Zip code | 3700033 | ||||||
| Address | 37-1, Nakaorui-machi, Takasaki city, Gunma, 370-0033, Japan | ||||||
| TEL | 027-352-1290 | ||||||
| Homepage URL | |||||||
| kimura@takasaki-u.ac.jp | |||||||
| Sponsor | |
| Institute | Takasaki University of Health and Welfare |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Takasaki University of Health and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Takasaki University of Health and Welfare |
| Address | 37-1, Nakaorui-machi, Takasaki city, Gunma, 370-0033, Japan |
| Tel | 027-352-1290 |
| mune@takasaki-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 8 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000037090 |